Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00658957 · ClinicalTrials.gov registry record · Phase 2
Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer
A Phase 2 study, sponsored by Innocoll.
- Terminated
- Registry status
- Phase 2
- Development phase
- 49
- Enrollment target
NCT00658957 is a Phase 2 study that was terminated before completion, run by Innocoll. The registered enrollment target is 49 participants.
The verdict
NCT00658957, a Phase 2 study, was terminated before completion, sponsored by Innocoll.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and efficacy of the topical gentamicin collagen sponge (gentamicin sponge) combined with standard of care (daily wound care, off-loading, diabetic control and debridement by a physician or podiatrist), compared with placebo sponge combined with standard of care, in preventing infection of diabetic lower extremity skin ulcers.
Interventions
- DRUG placebo collagen sponge
- DRUG gentamicin-collagen sponge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00658957
The ClinicalTrials.gov registry entry for NCT00658957 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Innocoll, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo collagen sponge is the first listed.
NCT00658957 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00658957 about?
NCT00658957 is a clinical study titled "Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer". The purpose of this study is to determine the safety and efficacy of the topical gentamicin collagen sponge (gentamicin sponge) combined with standard of care (daily wound care, off-loading, diabetic control and debridement by a physician or podiatrist), compared with placebo sponge combined with st...
What is the current status of trial NCT00658957?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2008-04. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00658957?
The interventions under investigation include: placebo collagen sponge (DRUG), gentamicin-collagen sponge (DRUG).
Who is sponsoring clinical trial NCT00658957?
This trial is sponsored by Innocoll, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.